Health
BioNTech Stock Pops Ahead Of Earnings; But Can Its Vaccine Tackle Delta? – Investor’s Business Daily
BioNTech stock popped Monday after the Covid-vaccine maker said it would announce second-quarter earnings results in a week.

BioNTech stock popped Monday after the Covid vaccine maker said it would announce second-quarter earnings results in a week.
XAnalysts polled by FactSet expect BioNTech (BNTX) to report adjusted earnings of $8.94 per share and almost $3.86 billion in sales….
Continue Reading
-
General20 hours ago
‘Potential’ hacker contacts Qantas over data breach
-
Noosa News6 hours ago
How Lily Steele-Park took her rapist to court and won
-
Business11 hours ago
Ford CEO makes stunning prediction about artificial intelligence
-
General22 hours ago
Fears for next anti-Semitic firebombing on home soil